Free Trial

Pasithea Therapeutics (KTTA) Institutional Ownership

Pasithea Therapeutics logo
$0.68 -0.01 (-0.77%)
Closing price 08/6/2025 04:00 PM Eastern
Extended Trading
$3.00 +2.32 (+337.96%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Pasithea Therapeutics (NASDAQ:KTTA)

Current
Institutional Ownership
Percentage
23.92%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$100.98K
Number of
Institutional Sellers
(last 12 months)
0
Get KTTA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Pasithea Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

KTTA Institutional Buying and Selling by Quarter

Pasithea Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/4/2025 AdvisorShares Investments LLC193,547$140K0.0%+261.5%2.601%
2/10/2023K2 Principal Fund L.P.282,437$181K0.0%-42.6%0.966%
5/12/2022Mark Sheptoff Financial Planning LLC48,000$62K0.0%N/A0.210%
2/11/2022K2 Principal Fund L.P.550,000$973K0.1%N/A4.164%
11/16/2021Two Sigma Securities LLC10,440$32K0.0%N/A0.080%
(Data available from 1/1/2016 forward)

KTTA Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of KTTA shares?

During the previous two years, the following institutional investors and hedge funds held shares of Pasithea Therapeutics shares: AdvisorShares Investments LLC ($140K).Learn more on Pasithea Therapeutics' institutional investors.

What percentage of Pasithea Therapeutics' stock is owned by institutional investors?

23.92% of Pasithea Therapeutics' stock is owned by institutional investors. Learn more on KTTA's institutional investor holdings.

Which institutional investors have been buying Pasithea Therapeutics' stock?

The following institutional investors have purchased Pasithea Therapeutics' stock in the last 24 months: AdvisorShares Investments LLC ($140K).

How much institutional buying is happening at Pasithea Therapeutics?

Institutional investors have bought a total of 140,000 shares in the last 24 months. This purchase volume represents approximately $100.98K in transactions.



This page (NASDAQ:KTTA) was last updated on 8/7/2025 by MarketBeat.com Staff
From Our Partners